XENE – xenon pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting [Financial Post (Toronto, Ontario, Canada)]
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $62.00 price target on the stock.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Form ARS Xenon Pharmaceuticals For: Dec 31
Form DEF 14A Xenon Pharmaceuticals For: Apr 26
Form 8-K Xenon Pharmaceuticals For: Apr 15
Form 4 Xenon Pharmaceuticals For: Mar 11 Filed by: Von Seggern Christopher
Form 4 Xenon Pharmaceuticals For: Mar 11 Filed by: AULIN SHERRY
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.